반응 #1014090

ord-0295166df82943b6b0de680cfa7facf9

반응 방정식

CN1CCOCC1
N-methylmorpholine
COC(=O)/C=C/C(=O)[O-]
mono methyl fumarate
COC(=O)[C@@H](N)CS.Cl
L-cysteine methyl ester hydrochloride
CCN=C=NCCCN(C)C
EDCI
COC(=O)/C=C/C(=O)N[C@@H](CS)C(=O)OC
(R,E)-methyl 4-(3-mercapto-1-methoxy-1-oxopropan-2-ylamino)-4-oxobut-2-enoate

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    세척The organic layer was washed with saturated aqueous NaHCO3 and brine
  2. 2
    건조The organic layer was dried (Na2SO4)
  3. 3
    농축concentrated under reduced pressure

실험 절차

Separately, mono methyl fumarate (100 mg, 0.77 mmol) was taken up in 4 mL of CH3CN along with L-cysteine methyl ester hydrochloride (132 mg, 0.77 mmol), EDCI (245 mg, 0.77 mmol) and N-methylmorpholine (85 μl, 0.77 mmol). The reaction mixture was stirred at room temperature for 3 h. It was then diluted with EtOAc. The organic layer was washed with saturated aqueous NaHCO3 and brine. The organic layer was dried (Na2SO4) and concentrated under reduced pressure to afford crude (R,E)-methyl 4-(3-mercapto-1-methoxy-1-oxopropan-2-ylamino)-4-oxobut-2-enoate. This material was then taken up in 3 mL of CH3CN along with (4Z,7Z,10Z,13Z,16Z,19Z)—N—(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethyl)docosa-4,7,10,13,16,19-hexaenamide (173 mg, 0.38 mmol) and stirred at room temperature for 30 min. The reaction mixture was then concentrated under reduced pressure. Purification by chromatography (CH2Cl2) afforded 60 mg of (E)-methyl 4-((R)-3-(1-(2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamidoethyl)-2,5-dioxopyrrolidin-3-ylthio)-1-methoxy-1-oxopropan-2-ylamino)-4-oxobut-2-enoate (22%). MS (EI) calcd for C37H51N3O8S: 697.34; found: 698 (M+1).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US09289503B2uspto-grants-2016_03